Table 1.
Day | Group | N | Mean | SD | Min | Max | χ2 | DF | p |
---|---|---|---|---|---|---|---|---|---|
2 | CG | 16 | 0.31 | 0.60 | 0.0 | 2.0 | 0.905 | 3 | 0.824 |
MG | 16 | 0.31 | 0.60 | 0.0 | 2.0 | ||||
G-CSF | 16 | 0.50 | 0.73 | 0.0 | 2.0 | ||||
G-CSF-M | 16 | 0.44 | 0.73 | 0.0 | 2.0 | ||||
CG | 16 | 1.69 | 2.89 | 0.0 | 9.0 | ||||
7 | MG | 16 | 1.13 | 0.62 | 0.0 | 3.0 | 4.938 | 3 | 0.176 |
G-CSF | 16 | 0.63 | 0.89 | 0.0 | 2.0 | ||||
G-CSF-M | 16 | 1.00 | 1.71 | 0.0 | 5.0 | ||||
14 | CG | 16 | 4.94 | 2.11 | 1.0 | 8.0 | 16.634 | 3 | 0.001 |
MG | 16 | 4.38 | 2.33 | 1.0 | 9.0 | ||||
G-CSF | 16 | 3.13 | 1.59 | 1.0 | 5.0 | ||||
G-CSF-M | 16 | 6.38 | 1.78 | 3.0 | 8.0 | ||||
21 | CG | 16 | 6.06 | 2.69 | 2.0 | 11.0 | 16.126 | 3 | 0.001 |
MG | 16 | 7.63 | 3.32 | 1.0 | 14.0 | ||||
G-CSF | 16 | 5.44 | 1.71 | 2.0 | 8.0 | ||||
G-CSF-M | 16 | 8.81 | 2.14 | 5.0 | 12.0 | ||||
28 | CG | 16 | 6.88 | 2.39 | 4.0 | 11.0 | 21.408 | 3 | <0.001 |
MG | 16 | 9.56 | 1.82 | 7.0 | 12.0 | ||||
G-CSF | 16 | 7.88 | 1.36 | 5.0 | 10.0 | ||||
G-CSF-M | 16 | 11.38 | 3.46 | 5.0 | 15.0 | ||||
35 | CG | 16 | 7.56 | 2.78 | 5.0 | 12.0 | 21.204 | 3 | <0.001 |
MG | 16 | 10.13 | 1.63 | 8.0 | 12.0 | ||||
G-CSF | 16 | 9.31 | 1.62 | 8.0 | 12.0 | ||||
G-CSF-M | 16 | 13.19 | 3.37 | 8.0 | 18.0 | ||||
42 | CG | 16 | 8.69 | 2.09 | 6.0 | 12.0 | 21.644 | 3 | <0.001 |
MG | 16 | 11.00 | 1.83 | 8.0 | 14.0 | ||||
G-CSF | 16 | 10.38 | 1.59 | 8.0 | 12.0 | ||||
G-CSF-M | 16 | 14.13 | 3.59 | 8.0 | 18.0 |
CG = control group; MG = methylprednisolone group; G-CSF = granulocyte colony-stimulating factor group and G-CSF-M = group receiving G-CSF and methylprednisolone.